Drugs Approved for Kidney (Renal Cell) Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for kidney (renal cell) cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in kidney (renal cell) cancer that are not listed here.
Drugs Approved for Kidney (Renal Cell) Cancer
- Afinitor (Everolimus)
Afinitor Disperz (Everolimus) - Aldesleukin
- Avastin (Bevacizumab)
- Avelumab
- Axitinib
- Bavencio (Avelumab)
- Bevacizumab
- Cabometyx (Cabozantinib-S-Malate)
- Cabozantinib-S-Malate
- Everolimus
- IL-2 (Aldesleukin)
- Inlyta (Axitinib)
- Interleukin-2 (Aldesleukin)
- Ipilimumab
- Jelmyto (Mitomycin)
- Keytruda (Pembrolizumab)
- Lenvatinib Mesylate
- Lenvima (Lenvatinib Mesylate)
- Mitomycin
- Mvasi (Bevacizumab)
- Nexavar (Sorafenib Tosylate)
- Nivolumab
- Opdivo (Nivolumab)
- Pazopanib Hydrochloride
- Pembrolizumab
- Proleukin (Aldesleukin)
- Sorafenib Tosylate
- Sunitinib Malate
- Sutent (Sunitinib Malate)
- Temsirolimus
- Torisel (Temsirolimus)
- Votrient (Pazopanib Hydrochloride)
- Yervoy (Ipilimumab)